Preliminary Studies Leading Toward the Development of a LIDAR Bathymetry Mapping Instrument

The National Aeronautics and Space Administration (NASA) at Goddard Space Flight Center (GSFC) has developed a laser ranging device (LIDAR) which provides accurate and timely data of earth features. NASA/GSFC recently modified the sensor to include a scanning capability to produce LIDAR swaths. They have also integrated a Global Positioning System (GPS) and an Inertial Navigation System (INS) to accurately determine the absolute aircraft location and aircraft attitude (pitch, yaw, and roll), respectively. The sensor has been flown in research mode by NASA for many years. The LIDAR has been used in different configurations or modes to acquire such data as altimetry (topography), bathymetry (water depth), laser-induced fluorosensing (tracer dye movements, oil spills and oil thickness, chlorophyll and plant stress identification), forestry, and wetland discrimination studies. NASA and HARC are developing a commercial version of the instrument for topographic mapping applications. The next phase of the commercialization project will be to investigate other applications such as wetlands mapping and coastal bathymetry. In this paper we report on preliminary laboratory measurements to determine the feasibility of making accurate depth measurements in relatively shallow water (approximately 2 to 6 feet deep) using a LIDAR system. The LIDAR bathymetry measurements are relatively simple in theory. The water depth is determined by measuring the time interval between the water surface reflection and the bottom surface reflection signals. Depth is then calculated by dividing by the index of refraction of water. However, the measurements are somewhat complicated due to the convolution of the water surface return signal with the bottom surface return signal. Therefore in addition to the laboratory experiments, computer simulations of the data were made to show these convolution effects in the return pulse waveform due to: (1) water depth, and (2) changes in bottom surface reflectivity

Structure–activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors

Recently we described a novel pyranopyridine inhibitor (MBX2319) of RND-type efflux pumps of the Enterobacteriaceae. MBX2319 (3,3-dimethyl-5-cyano-8-morpholino-6-(phenethylthio)-3,4-dihydro-1H-pyrano[3,4-c]pyridine) is structurally distinct from other known Gram-negative efflux pump inhibitors (EPIs), such as 1-(1-naphthylmethyl)-piperazine (NMP), phenylalanylarginine-β-naphthylamide (PAβN), D13-9001, and the pyridopyrimidine derivatives. Here, we report the synthesis and biological evaluation of 60 new analogs of MBX2319 that were designed to probe the structure activity relationships (SARs) of the pyranopyridine scaffold. The results of these studies produced a molecular activity map of the scaffold, which identifies regions that are critical to efflux inhibitory activities and those that can be modified to improve potency, metabolic stability and solubility. Several compounds, such as 22d–f, 22i and 22k, are significantly more effective than MBX2319 at potentiating the antibacterial activity of levofloxacin and piperacillin against Escherichia coli

Factors Associated with Revision Surgery after Internal Fixation of Hip Fractures

Background: Femoral neck fractures are associated with high rates of revision surgery after management with internal fixation. Using data from the Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) trial evaluating methods of internal fixation in patients with femoral neck fractures, we investigated associations between baseline and surgical factors and the need for revision surgery to promote healing, relieve pain, treat infection or improve function over 24 months postsurgery. Additionally, we investigated factors associated with (1) hardware removal and (2) implant exchange from cancellous screws (CS) or sliding hip screw (SHS) to total hip arthroplasty, hemiarthroplasty, or another internal fixation device. Methods: We identified 15 potential factors a priori that may be associated with revision surgery, 7 with hardware removal, and 14 with implant exchange. We used multivariable Cox proportional hazards analyses in our investigation. Results: Factors associated with increased risk of revision surgery included: female sex, [hazard ratio (HR) 1.79, 95% confidence interval (CI) 1.25-2.50; P = 0.001], higher body mass index (fo

Poly-Si on glass thin-film PV research at UNSW

Thin-film polycrystalline silicon (poly-Si) on glass is a promising material for lowering the cost of PV electricity. This paper gives an update on the poly-Si on glass thin-film PV research in our group at the University of New South Wales (UNSW). Each of the investigated Si formation methods (solid phase crystallisation, solid phase epitaxy, ion-assisted deposition) is shown to be capable of producing device-grade Si material, with voltages in the 440-530 mV range. Fill factors of over 70% are now frequently obtained using an interdigitated cell metallisation scheme. The best cells presently have efficiencies of 7% and are improving rapidly

Network abnormalities and interneuron dysfunction in Alzheimer disease

The function of neural circuits and networks can be controlled, in part, by modulating the synchrony of their components' activities. Network hypersynchrony and altered oscillatory rhythmic activity may contribute to cognitive abnormalities in Alzheimer disease (AD). In this condition, network activities that support cognition are altered decades before clinical disease onset, and these alterations predict future pathology and brain atrophy. Although the precise causes and pathophysiological consequences of these network alterations remain to be defined, interneuron dysfunction and network abnormalities have emerged as potential mechanisms of cognitive dysfunction in AD and related disorders. Here, we explore the concept that modulating these mechanisms may help to improve brain function in these conditions

Biomarkers, genetic association, and genomic studies

Rheumatoid arthritis (RA) is a common autoimmune disorder which shows clinical heterogeneity. IT has multiple treatment options and there is individual variation in response to treatment. These features make RA an ideal condition to develop biomarkers for its pre-clinical detection, diagnosis, subtyping, prognostic stratification and selection of most optimal treatment. While a number of markers have been assessed for their biomarker quality, currently no marker has the statistical properties of a biomarker to be considered as a good classifier. In this chapter, a general review of biomarkers is followed by a detailed discussion of biomarker candidates for various aspects of RA. It is unlikely that a single marker will ever be sufficiently powerful as a biomarker, but combinations of clinical, biochemical, genetic, epigenetic, proteomic and metabolomic markers have the strongest potential to fulfill the requirements of biomarkers. Given the high heritability of RA and the progress in methodology of genome-wide association studies, genetic markers are the most promising group to be developed as biomarkers, in particular when epigenetic markers become more widely used. It is possible that in the near future, biomarkers with documented clinical utility will be available for use in clinical decision making and will most probably use multiple omics platforms